IL6 and gastric cancer: Proteomics biomarker discovery applied to GC research has succeeded in the identification of potential predictive diagnostic biomarkers (i.e., HLA-G, IL-6, PD-1), evidenced aberrant GC disease-related glycosignatures (i.e., N-glycosylation), and found in circulating exosomal cargo a new important source of diagnostic markers (i.e., TRIM3, GKN1, and HLA-G).